Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix

Autor(es)

Motta, G ^[1] ; Shariat-Madar, Z ^[2] ; Mahdi, F ^[3] ; Sampaio, CAM ^[4] ; Schmaier, AH ^[5]

Afiliação do(s) autor(es)

^[1] Universidade Federal de São Paulo (UNIFESP-EPM) - Brasil

^[2] Department of Internal Medicine, University of Michigan, Ann Arbor, MI - Estados Unidos

^[3] Department of Internal Medicine, University of Michigan, Ann Arbor, MI - Estados Unidos

^[4] Universidade Federal de São Paulo (UNIFESP-EPM) - Brasil

^[5] Department of Internal Medicine, University of Michigan, Ann Arbor, MI - Estados Unidos

• Tipo de documento: Artigo Científico
• Fonte: THROMBOSIS AND HAEMOSTASIS; v. 86, n. 3, p. 840-847, 2001.

Resumo

Investigations determined if extracellular matrix of endothelial cells (EC) is a platform for HK assembly and PK activation. In buffers containing bovine serum albumin, biotin-HK binding to ECV304 cells or their matrix requires > 50 µM added Zn2+. Ortho-phenanthroline or a HK domain 5 peptide blocks HK binding. Binding to umbilical vein EC or matrix, but not ECV304 cells or matrix, is mediated by cytokeratin 1. Biotin-HK binds to ECV304 cells or matrix with a Kyd of 15.8 or 9.0 nM and a Bmax of 2.6x107 or 2.4x107 sites/cell, respectively. PK activation on ECV304 cells or matrix is blocked by antipain or SBTI and corn trypsin inhibitor partially inhibits kallikrein formation. PK activation occurs on ECV304 cells or matrix prepared without serum or in human factor XII deficient serum, indicating that the PK activator is not factor XIIa. EC matrix promotes plasminogen activation after the assembly of HK, PK and pro-urokinase. These studies indicate that matrix of various EC has the ability to assemble HK allowing for PK activation and subsequent activities. (AU)

• Processo FAPESP: 96/05074-5 - Estudo da ativacao da procalicreina plasmatica na superficie da celula endotelial.
• Beneficiário: Guacyara da Motta
• Linha de fomento: Auxílio à Pesquisa - Regular